ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,113Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 780

$928K Total Retail Price of All Prescriptions

Rank: 80 out of 780

1,005 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,005 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

35% of this provider’s 1,005 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 10,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,938 617 S3 1 1
OMEPRAZOLE 778 434 2 3
AMLODIPINE BESYLATE 730 501 3 4
LISINOPRIL 703 430 4 6
TIZANIDINE HCL 619 142 5 82
FUROSEMIDE 496 368 6 7
AZITHROMYCIN 493 209 7 38
HYDROCHLOROTHIAZIDE 456 273 8 10
METFORMIN HCL 391 229 9 8
SIMVASTATIN 380 275 10 2
TRAMADOL HCL 319 158 11 15
ZOLPIDEM TARTRATE 290 131 12 17
WARFARIN SODIUM 254 190 13 24
GABAPENTIN 252 125 14 13
LEVOTHYROXINE SODIUM 245 177 15 5
CYCLOBENZAPRINE HCL 238 57 R 16 42
CARVEDILOL 231 146 17 14
CITALOPRAM HBR 228 125 18 23
ATENOLOL 219 134 19 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 219 108 19 26
POTASSIUM CHLORIDE 218 151 21 11
NEXIUM 203 58 22 22
PROMETHAZINE HCL 202 47 R 23 66
SERTRALINE HCL 195 88 24 27
PREDNISONE 192 81 25 40
PANTOPRAZOLE SODIUM 184 126 26 25
CIPROFLOXACIN HCL 183 124 27 49
LEVOFLOXACIN 178 97 28 76
ADVAIR DISKUS 173 72 29 68
LYRICA 167 55 30 52
CLONIDINE HCL 163 83 31 28
METOPROLOL TARTRATE 158 100 32 19
AMOXICILLIN 157 70 33 99
PROAIR HFA 148 57 34 62
DONEPEZIL HCL 147 137 35 31
ATORVASTATIN CALCIUM 144 94 36 12
RISPERIDONE 141 104 37 98
NAPROXEN 136 68 38 100
CLOPIDOGREL 135 102 39 34
GLIPIZIDE 131 96 40 74
MELOXICAM 127 92 41 16
LANTUS 114 62 42 71
VENTOLIN HFA 113 15 43 91
PRAVASTATIN SODIUM 108 84 44 9
PLAVIX 106 77 45 45
MECLIZINE HCL 104 63 46 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 49 46 88
NAMENDA 103 103 48 46
TRAZODONE HCL 101 43 49 35
AMITRIPTYLINE HCL 100 37 R 50 48
FLUCONAZOLE 100 52 50 111
ALLOPURINOL 95 78 52 29
AMOX TR-POTASSIUM CLAVULANATE 90 42 53 135
METOCLOPRAMIDE HCL 88 70 54 102
QUETIAPINE FUMARATE 88 49 54 81
DIOVAN 88 65 54 55
ESCITALOPRAM OXALATE 87 53 57 61
INSULIN SYRINGE 83 22 58 80
DIGOXIN 81 73 59 56
LEVETIRACETAM 81 46 59 130
BENAZEPRIL HCL 79 68 61 59
SPIRIVA 78 47 62 72
CRESTOR 76 55 63 32
GLIMEPIRIDE 74 38 64 30
FLUTICASONE PROPIONATE 65 34 65 41
PROPRANOLOL HCL 65 41 65 133
KLOR-CON M10 64 53 67 168
CARISOPRODOL 64 0 R 67 67
TAMSULOSIN HCL 63 59 69 36
RANITIDINE HCL 62 22 70 39
HYDROXYZINE HCL 61 32 R 71 155
PHENYTOIN SODIUM EXTENDED 60 22 72 128
FENTANYL 58 33 S2 73 107
SINGULAIR 58 17 73 73
MEGESTROL ACETATE 56 43 R 75 161
INDOMETHACIN 52 22 R 76 261
VENLAFAXINE HCL ER 51 11 77 117
COMBIVENT 50 14 78 189
CYMBALTA 50 14 78 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.